Integer (ITGR) Competitors

Integer (NYSE:ITGR) and Biodesix (NASDAQ:BDSX) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.

Do analysts rate ITGR or BDSX?

Integer currently has a consensus price target of $140.25, suggesting a potential upside of 31.39%. Biodesix has a consensus price target of $1.75, suggesting a potential upside of 341.92%. Given Biodesix's higher probable upside, analysts clearly believe Biodesix is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.00
Biodesix	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

Which has preferable earnings & valuation, ITGR or BDSX?

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.72B	2.18	$119.90M	$2.27	47.02
Biodesix	$76.56M	0.76	-$42.93M	-$0.29	-1.37

Is ITGR or BDSX more profitable?

Integer has a net margin of 4.61% compared to Biodesix's net margin of -53.66%. Integer's return on equity of 12.27% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	4.61%	12.27%	6.23%
Biodesix	-53.66%	-269.67%	-43.94%

Which has more volatility and risk, ITGR or BDSX?

Integer has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, Biodesix has a beta of 0.99, suggesting that its share price is 1% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of ITGR or BDSX?

99.3% of Integer shares are owned by institutional investors. Comparatively, 21.0% of Biodesix shares are owned by institutional investors. 2.2% of Integer shares are owned by insiders. Comparatively, 30.1% of Biodesix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Does the media favor ITGR or BDSX?

In the previous week, Integer had 8 more articles in the media than Biodesix. MarketBeat recorded 14 mentions for Integer and 6 mentions for Biodesix. Integer's average media sentiment score of 1.22 beat Biodesix's score of -0.47 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Biodesix	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Integer beats Biodesix on 15 of the 17 factors compared between the two stocks.